Home/Filings/4/0001019687-10-000263
4//SEC Filing

BIOFORM MEDICAL INC 4

Accession 0001019687-10-000263

CIK 0001282393operating

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 8:36 PM ET

Size

7.6 KB

Accession

0001019687-10-000263

Insider Transaction Report

Form 4
Period: 2010-01-19
Transactions
  • Sale

    Common Stock

    2010-01-19$5.51/sh70,508$388,647429,492 total(indirect: By Biotechnology Development Fund, L.P.)
Transactions
  • Sale

    Common Stock

    2010-01-19$5.51/sh70,508$388,647429,492 total(indirect: By Biotechnology Development Fund, L.P.)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]The reported securities are owned directly by Biotechnology Development Fund, L.P. and indirectly by BioAsia Investments, LLC, as general partner of Biotechnology Development Fund, L.P. BioAsia Investments, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.

Issuer

BIOFORM MEDICAL INC

CIK 0001282393

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001282393

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 8:36 PM ET
Size
7.6 KB